Texts that could transform trans teen sexual health

NCT ID NCT07681908

Not yet recruiting Prevention Sponsor: Center for Innovative Public Health Research Source: ClinicalTrials.gov ↗

First seen Jul 02, 2026 · Last updated Jul 02, 2026

Summary

This study tests a 5-month text-messaging program called #TranscendentHealth, created specifically for transgender boys and gender-diverse youth assigned female at birth, ages 14 to 18. The program aims to improve condom use, birth control use, and HIV/STI testing by addressing the unique needs and experiences of these teens. Participants are randomly assigned to receive either the tailored program or a general sexual health text program, and complete surveys over about a year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: #TranscendentHealth text messaging program
What this could lead to: If effective, this could provide a scalable, private way to improve sexual health and reduce unintended pregnancy among transgender and gender-diverse youth.
What could go wrong: This is an early-stage adaptation of an existing program, and its success depends on whether the tailored content engages participants better than a general program. Results may not apply to all youth.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Sexual Behavior HIV infectious disease prevention target sexually transmitted disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV INFECTION PREGNANCY (UNWANTED) SEXUAL BEHAVIOR SEXUALLY TRANSMITTED DISEASE (STD)

Contacts and locations

Locations

Center for Innovative Public Health Research (CiPHR)

San Clemente, California, 92672, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.